Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Equity (2021 - 2025)

Historic Return on Equity for Bioventus (BVS) over the last 4 years, with Q3 2025 value amounting to 0.05%.

  • Bioventus' Return on Equity changed N/A to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year change of. This contributed to the annual value of 0.24% for FY2023, which is 1000.0% down from last year.
  • As of Q3 2025, Bioventus' Return on Equity stood at 0.05%.
  • Bioventus' Return on Equity's 5-year high stood at 0.16% during Q2 2021, with a 5-year trough of 0.6% in Q3 2023.
  • Its 4-year average for Return on Equity is 0.11%, with a median of 0.02% in 2025.
  • As far as peak fluctuations go, Bioventus' Return on Equity tumbled by -1100bps in 2022, and later crashed by -6000bps in 2023.
  • Quarter analysis of 4 years shows Bioventus' Return on Equity stood at 0.03% in 2021, then tumbled by -736bps to 0.17% in 2022, then plummeted by -91bps to 0.33% in 2023, then skyrocketed by 115bps to 0.05% in 2025.
  • Its Return on Equity stands at 0.05% for Q3 2025, versus 0.03% for Q2 2025 and 0.02% for Q1 2025.